Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma

Cancer Chemotherapy and Pharmacology

Volumn 67, Issue 5, 2011, Pages 1027-1034

  Airoldi, Mario ^a   Gabriele, Pietro ^b   Gabriele, Anna Maria ^a   Garzaro, Massimiliano ^c   Raimondo, Luca ^c   Pedani, Fulvia ^a   Beatrice, Fabio ^d   Pecorari, Giancarlo ^c   Giordano, Carlo ^c  

^a MOLINETTE HOSPITAL   (Italy)

^b CANDIOLO CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d S GIOVANNI BOSCO HOSPITAL   (Italy)

Author keywords

Carboplatin; Chemoradiation; Nasopharyngeal carcinoma; Neoadjuvant chemotherapy; Taxol

Indexed keywords

CARBOPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; GABAPENTIN; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; RANITIDINE;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; ANEMIA; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CARDIOTOXICITY; CLINICAL ARTICLE; DISTANT METASTASIS; DRUG TOLERABILITY; FEBRILE NEUTROPENIA; FEMALE; HUMAN; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SIDE EFFECT; SKIN TOXICITY; THROMBOCYTOPENIA; WEIGHT REDUCTION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; PACLITAXEL; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 79955557725     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-010-1399-5     Document Type: Article

References (22)

1. J Guigay S Temam J Bourhis, et al. 2006 Nasopharyngeal carcinoma and therapeutic management: the place of chemotherapy Ann Oncol 17 suppl 10 x304 x307 17018743 10.1093/annonc/mdl278 (Pubitemid 44542027)
2. International Nasopharynx Cancer Study Group 1996 VUMCA I trial: preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, belomycin) plus radiotherapy vs. radiotherapy alone in stage IV (N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival Int J Radiat Oncol Biol Phys 35 463 469 10.1016/S0360-3016(96)80007-1
3. DT Chua JS Sham D Choy, et al. 1998 Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with locoregionally advanced nasopharyngeal arcinoma Cancer 83 2270 2283 9840526 10.1002/(SICI)1097-0142(19981201)83:11<2270::AID- CNCR6>3.3.CO;2-K 1:CAS:528:DyaK1cXnvFKqsL8%3D (Pubitemid 28533496)
4. J Ma HQ Mai MH Hong, et al. 2001 Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma J Clin Oncol 19 1350 1357 11230478 1:CAS:528:DC%2BD3MXit1ert7Y%3D (Pubitemid 32202540)
5. M Haeryama K Sakata H Shirato, et al. 2002 A prospective randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in advanced nasopharyngeal carcinoma Cancer 94 2217 2223 10.1002/cncr.10473 (Pubitemid 34411980)
6. JL Oh EE Vokes MS Kies, et al. 2003 Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer Ann Oncol 14 564 569 12649102 10.1093/annonc/mdg163 1:STN:280:DC%2BD3s7jsVSjtg%3D%3D (Pubitemid 41295084)
7. D Rischin J Corry J Smith, et al. 2002 Excellent disease control and survival in patients with advanced nasopharyngeal cancer treated with chemoradiation J Clin Oncol 20 1845 1852 11919243 10.1200/JCO.2002.07.011 1:CAS:528:DC%2BD38XjtFGqsrg%3D (Pubitemid 34273275)
8. A Al-Amro N Al Rajhi J Khafaga, et al. 2005 Neoadjuvant chemotherapy followed by concurrent chemoradiation therapy in locally advanced nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 62 2 508 513 15890594 10.1016/j.ijrobp.2004.09.050 (Pubitemid 40704469)
9. M Airoldi AM Gabriele M Garzaro, et al. 2009 Induction Chemotherapy with Cisplatin and Epirubicin followed by radiotherapy and concurrent Cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population Radiother Oncol 92 1 105 110 19264368 10.1016/j.radonc.2009.02.005 1:CAS:528:DC%2BD1MXnsFSisrk%3D
10. M Airoldi F Pedani S Marchionatti, et al. 2002 Carboplatin plus taxol is an effective third-line regimen in recurrent undifferentiated nasopharyngeal carcinoma Tumori 88 4 273 276 12400975 1:CAS:528:DC%2BD38XoslGjt78%3D
11. EH Tan KS Khoo J Wee, et al. 1999 Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma Ann Oncol 10 2 235 237 10093695 10.1023/A:1008390929826 1:STN:280:DyaK1M7ptlKmtw%3D%3D (Pubitemid 29113186)
12. W Yeo TW Leung AT Chan, et al. 1998 A phase II study combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma Eur J Cancer 34 13 2027 2031 10070305 10.1016/S0959-8049(98)00280-9 1:CAS:528: DyaK1MXitVWhtA%3D%3D (Pubitemid 28546936)
13. AD Seidman 1998 One-hour paclitaxel via weekly infusion: dose-density with enhanced therapeutic index Oncology 12 19 22 9516598 1:STN:280: DyaK1c7nslansw%3D%3D (Pubitemid 28113734)
14. AW Lee WM Sze JS Au, et al. 2005 Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience Int J Radiat Oncol Biol Phys 61 1107 1116 15752890 10.1016/j.ijrobp.2004.07.702 (Pubitemid 40340904)
15. B Baujat H Audry J Bourhis, et al. 2006 Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized clinical trials and 1753 patients Int J Radiat Oncol Biol Phys 64 47 56 16377415 10.1016/j.ijrobp.2005.06.037 1:CAS:528:DC%2BD2MXhtlCqur3P (Pubitemid 41831208)
16. DT Chua J Ma JS Sham, et al. 2005 Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials J Clin Oncol 23 1118 1124 15657403 10.1200/JCO.2005.12.081 1:CAS:528:DC%2BD2MXitl2gtbk%3D (Pubitemid 46202267)
17. AT Chan PM Teo TW Leung, et al. 1995 A prospective randomized study of chemotherapy adjunctive to definitive radiotherapy in advanced nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 33 569 577 7558945 10.1016/0360-3016(95) 00218-N 1:CAS:528:DyaK2MXpsl2ktLY%3D
18. Chan ATC, Ma BBY, Lo D et al (2004) Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr Virus DNA. J Clin Oncol 22;15:3053-3060 (Pubitemid 41103717)
19. I Chitapanarux W Lorvidhaya P Kamnerdsupaphon, et al. 2007 Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: randomised, non inferiority, open trial Eur J Cancer 43 9 1399 1406 17467265 10.1016/j.ejca.2007.03.022 1:CAS:528:DC%2BD2sXmtlagsLw%3D (Pubitemid 46874069)
20. NM Kramer EM Horwitz J Cheng, et al. 2005 Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies Head Neck 27 5 406 414 15719391 10.1002/hed.20163 (Pubitemid 40593895)
21. SA Spencer J Harris RH Weeler, et al. 2008 Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck Head Neck 30 3 281 288 17764087 10.1002/hed.20697 (Pubitemid 351480742)
22. CJ Langer J Harris EM Horwitz, et al. 2007 Phase II study of low dose paclitaxel and cisplatin in combination with split course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911 J Clin Oncol 25 30 4800 4805 17947728 10.1200/JCO.2006.07.9194 1:CAS:528:DC%2BD2sXhtlCgsLbK (Pubitemid 350086484)